EE200000652A - Farmatseutiline kompositsioon ja produkt - Google Patents

Farmatseutiline kompositsioon ja produkt

Info

Publication number
EE200000652A
EE200000652A EEP200000652A EEP200000652A EE200000652A EE 200000652 A EE200000652 A EE 200000652A EE P200000652 A EEP200000652 A EE P200000652A EE P200000652 A EEP200000652 A EE P200000652A EE 200000652 A EE200000652 A EE 200000652A
Authority
EE
Estonia
Prior art keywords
product
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
EEP200000652A
Other languages
English (en)
Inventor
Harrison Pickar James
Samuel Komm Barry
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000652(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000652A publication Critical patent/EE200000652A/et
Publication of EE04262B1 publication Critical patent/EE04262B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
EEP200000652A 1998-05-15 1999-05-11 Östrogeeni ja 2-fenüül-1-[4-(2-aminoetoksü)bensüül]indooli ühendit sisaldav farmatseutiline kompositsioon ja produkt EE04262B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15
PCT/US1999/010217 WO1999059581A1 (en) 1998-05-15 1999-05-11 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Publications (2)

Publication Number Publication Date
EE200000652A true EE200000652A (et) 2002-04-15
EE04262B1 EE04262B1 (et) 2004-04-15

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000652A EE04262B1 (et) 1998-05-15 1999-05-11 Östrogeeni ja 2-fenüül-1-[4-(2-aminoetoksü)bensüül]indooli ühendit sisaldav farmatseutiline kompositsioon ja produkt

Country Status (42)

Country Link
EP (1) EP1076558B1 (et)
JP (3) JP2002515431A (et)
KR (1) KR100620772B1 (et)
CN (1) CN1230163C (et)
AP (1) AP1424A (et)
AR (1) AR020074A1 (et)
AT (1) ATE245026T1 (et)
AU (1) AU760378B2 (et)
BE (1) BE2015C026I2 (et)
BG (1) BG64783B1 (et)
BR (1) BR9911040A (et)
CA (1) CA2329530A1 (et)
CU (1) CU23241B7 (et)
CY (1) CY2015020I1 (et)
CZ (1) CZ299334B6 (et)
DE (1) DE69909616T2 (et)
DK (1) DK1076558T3 (et)
EA (1) EA005932B1 (et)
EE (1) EE04262B1 (et)
ES (1) ES2203131T3 (et)
FR (1) FR15C0035I2 (et)
GE (1) GEP20033079B (et)
HK (1) HK1031691A1 (et)
HR (1) HRP20000778B1 (et)
HU (2) HU226587B1 (et)
ID (1) ID26890A (et)
IL (1) IL139130A (et)
IN (1) IN192220B (et)
LT (1) LTC1076558I2 (et)
LU (1) LU92699I2 (et)
NO (2) NO328129B1 (et)
NZ (1) NZ508200A (et)
OA (1) OA11552A (et)
PL (1) PL194750B1 (et)
PT (1) PT1076558E (et)
SI (1) SI1076558T1 (et)
SK (1) SK284666B6 (et)
TR (1) TR200003377T2 (et)
TW (1) TW565554B (et)
UA (1) UA66861C2 (et)
WO (1) WO1999059581A1 (et)
ZA (1) ZA200006959B (et)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
WO2001001969A2 (en) 1999-07-06 2001-01-11 Endorecherche, Inc. Methods of treating and/or suppressing weight gain
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AU2001273125A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
CA2414060A1 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of statins, estrogenic agents and optionally estrogens
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
CZ2004118A3 (cs) 2001-07-31 2004-09-15 Pfizer Products Inc. Farmaceutický prostředek, kit a způsoby zahrnující kombinaci činidla estrogenový agonist/antagonist, estrogenu a progestinu
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
DK2276732T3 (en) 2008-04-16 2015-08-17 Karobio Ab Novel østrogenreceptorligander
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
AU2018386201A1 (en) * 2017-12-15 2020-07-30 Bristol-Myers Squibb Company Substituted indole ether compounds
IT201800006562A1 (it) 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
JP2023517393A (ja) * 2020-03-17 2023-04-25 メッドシャイン ディスカバリー インコーポレイテッド タンパク質分解調整剤およびその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
EP0639567A1 (en) * 1992-05-08 1995-02-22 Otsuka Pharmaceutical Factory, Inc. Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
ES2162198T3 (es) * 1996-04-19 2001-12-16 American Home Prod Agentes estrogenos.
CA2259598A1 (en) * 1996-07-09 1998-01-15 Smithkline Beecham S.P.A. Indole derivatives for the treatment of osteoporosis
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
KR100669836B1 (ko) * 1997-10-15 2007-01-18 와이어쓰 신규한 아릴옥시-알킬-디알킬아민 및 이의 제조 방법
WO1999021557A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.

Also Published As

Publication number Publication date
NO20005770L (no) 2001-01-12
AR020074A1 (es) 2002-04-10
CA2329530A1 (en) 1999-11-25
KR20010043641A (ko) 2001-05-25
WO1999059581A1 (en) 1999-11-25
HRP20000778A2 (en) 2001-06-30
ID26890A (id) 2001-02-15
DE69909616T2 (de) 2004-06-17
EP1076558A1 (en) 2001-02-21
IL139130A0 (en) 2001-11-25
DE69909616D1 (de) 2003-08-21
GEP20033079B (en) 2003-10-27
PL345268A1 (en) 2001-12-03
CY2015020I1 (el) 2020-05-29
CZ299334B6 (cs) 2008-06-25
FR15C0035I1 (et) 2015-06-26
EA005932B1 (ru) 2005-08-25
HUS1500023I1 (hu) 2017-03-28
TW565554B (en) 2003-12-11
IN192220B (et) 2004-03-20
AP1424A (en) 2005-06-06
BR9911040A (pt) 2001-02-13
ZA200006959B (en) 2001-11-27
SK17202000A3 (sk) 2001-07-10
BG64783B1 (bg) 2006-04-28
BE2015C026I2 (en) 2018-08-24
CU23241B7 (es) 2007-10-17
AU3894499A (en) 1999-12-06
NO328129B1 (no) 2009-12-14
EA200001193A1 (ru) 2001-12-24
NO2015015I2 (no) 2015-06-02
PL194750B1 (pl) 2007-06-29
AU760378B2 (en) 2003-05-15
CN1326347A (zh) 2001-12-12
SI1076558T1 (en) 2003-10-31
JP2009019042A (ja) 2009-01-29
CN1230163C (zh) 2005-12-07
EE04262B1 (et) 2004-04-15
ATE245026T1 (de) 2003-08-15
LU92699I2 (fr) 2015-06-24
NO2015015I1 (no) 2015-06-02
FR15C0035I2 (fr) 2015-08-28
AP2000001970A0 (en) 2000-12-31
JP5872624B2 (ja) 2016-03-01
IL139130A (en) 2005-11-20
NZ508200A (en) 2003-09-26
UA66861C2 (uk) 2004-06-15
HU226587B1 (en) 2009-04-28
PT1076558E (pt) 2003-11-28
EP1076558B1 (en) 2003-07-16
HRP20000778B1 (en) 2004-10-31
HUP0103096A2 (hu) 2002-05-29
JP5607871B2 (ja) 2014-10-15
KR100620772B1 (ko) 2006-09-13
DK1076558T3 (da) 2003-11-03
SK284666B6 (sk) 2005-08-04
HUP0103096A3 (en) 2002-11-28
JP2002515431A (ja) 2002-05-28
JP2014159472A (ja) 2014-09-04
TR200003377T2 (tr) 2001-03-21
BG104930A (en) 2001-07-31
CZ20004254A3 (cs) 2001-12-12
LTC1076558I2 (lt) 2016-11-10
NO20005770D0 (no) 2000-11-14
OA11552A (en) 2004-06-07
ES2203131T3 (es) 2004-04-01
HK1031691A1 (en) 2001-06-22

Similar Documents

Publication Publication Date Title
EE200000652A (et) Farmatseutiline kompositsioon ja produkt
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
NO953657L (no) Nytt farmasöytisk produkt
DK0920302T3 (da) Farmaceutisk aerosolsammensætning
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID24654A (id) Formulasi farmasi omeprazola
PT102291A (pt) Metanossulfonato de paroxetina processos para a sua preparacao composicao farmaceutica contendo o mesmo e sua utilizacao
FI973475A (fi) Koostumus ja sitä sisältävä tuote
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
ID27150A (id) Sediaan levotiroksin bahan farmasi
EE9900545A (et) Farmatseutiline kompositsioon
DE69820861D1 (de) Teilchenförmige arzneimittelträger
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
NO991013L (no) Krystallinsk farmas°ytisk produkt
EE200000020A (et) 2,4,4-triasendatud-1,3-dioksolaanid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon, kombinatsioon ja produkt
ID23531A (id) Komposisi farmasi
ATA173599A (de) Pharmazeutisches produkt
BR1101151A (pt) Compostos e composição farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
BR1100929A (pt) Derivados 1,2-difenilpirrol e uma composição farmacêutica
BR1100755A (pt) composição farmacêutica
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
FI982793A0 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI3163U1 (fi) Lääkesäiliö

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
AA1Y Spc filed

Free format text: PRODUCT NAME: KONJUGEERITUD OESTROGEENID JA BASEDOKSIFEEN;REG NO/DATE: EU/1/14/960 18.12.2014

Spc suppl protection certif: C20150021

Filing date: 20150529

FG1Y Spc granted

Free format text: PRODUCT NAME: KONJUGEERITUD OESTROGEENID JA BASEDOKSIFEEN;REG NO/DATE: EU/1/14/960 18.12.2014

Spc suppl protection certif: C20150021 00158

Filing date: 20150529

Extension date: 20240511

SPCT Party data change related to a supplementary protection certificate

Owner name: WYETH LLC, NY 10001 2192, US

Spc suppl protection certif: 00158